Avaí Bio and Austrianova Complete GMP Master Cell Bank, Begin Viral Testing for Cell-Based Klotho Anti-Aging Therapy

by Walter Gunzburg | May 21, 2026 | News

LAS VEGAS, May 20, 2026 /PRNewswire/ — Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”), an emerging biotechnology company developing transformative cell-based therapies for diabetes, age-related disorders, and anti-aging, today...

SG Austria/Austrianova Announces the Appointment of C. Thomas Paschall, to the Board following the Successful closing of 2025 Financing Round Led by Checkmate Capital Group

by Walter Gunzburg | Apr 23, 2026 | News

“SG Austria/Austrianova appoints biotech investor C. Thomas Paschall to its Board following a successful 2025 funding round, strengthening global growth, partnerships, and strategic expansion initiatives.”   SINGAPORE – April 21, 2026 – SG...

Avant Technologies and Austrianova Secure Exclusive License for Klotho Producing Cell Line to Advance Anti-Aging Therapies

by Walter Gunzburg | Nov 19, 2025 | News, Press Release

LAS VEGAS, NEVADA, November 18, 2025 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology company focused on developing cell-based therapies for diabetes and age-related disorders, today announced that its 50/50 joint venture...

Avant Technologies and Austrianova Sign Joint Venture, Licensing Agreement to Advance Klotho-Based Therapies

by Walter Gunzburg | Sep 19, 2025 | News, Press Release

LAS VEGAS, Sept. 18, 2025 /PRNewswire/ — Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), a Nevada-based corporation, and Austrianova (SGAustria Pte. Ltd.), a Singapore-based biotechnology leader, today announced the...

Long-Term Survival of Cellulose Sulphate-Encapsulated Cells and Metronomic Ifosfamide Control Tumour Growth in Pancreatic Cancer Models—A Prelude to Treating Solid Tumours Effectively in Pets and Humans

by Walter Gunzburg | Aug 17, 2024 | Scientific Publications

Austrianova Singapore Pte Ltd., 2 International Business Park, The Strategy @ IBP #09-04, Singapore 609930, Singapore; salmons@sgaustria.com Institute of Virology, Department of Pathobiology, University of Veterinary Medicine, 1210 Vienna, Austria* Correspondence:...